Leebeek FW - Search Results

1

Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma.

Auwerda JJ, Yuana Y, Osanto S, de Maat MP, Sonneveld P, Bertina RM, Leebeek FW. Auwerda JJ, et al. Among authors: leebeek fw. Thromb Haemost. 2011 Jan;105(1):14-20. doi: 10.1160/TH10-03-0187. Epub 2010 Nov 5. Thromb Haemost. 2011. PMID: 21057704 Clinical Trial.

2

Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris.

Brouwers GJ, Leebeek FW, Tanck MW, Wouter Jukema J, Kluft C, de Maat MP. Brouwers GJ, et al. Among authors: leebeek fw. Thromb Haemost. 2003 Jul;90(1):92-100. Thromb Haemost. 2003. PMID: 12876631

3

Successful treatment of systemic amyloidosis with hepatic involvement and factor X deficiency by high dose melphalan chemotherapy and autologous stem cell reinfusion.

Breems DA, Sonneveld P, de Man RA, Leebeek FW. Breems DA, et al. Among authors: leebeek fw. Eur J Haematol. 2004 Mar;72(3):181-5. doi: 10.1046/j.0902-4441.2003.00200.x. Eur J Haematol. 2004. PMID: 14962236

4

Functional characteristics of photochemically treated platelets.

Jansen GA, van Vliet HH, Vermeij H, Beckers EA, Leebeek FW, Sonneveld P, van Rhenen DJ. Jansen GA, et al. Among authors: leebeek fw. Transfusion. 2004 Mar;44(3):313-9. doi: 10.1111/j.1537-2995.2003.00588.x. Transfusion. 2004. PMID: 14996186

5

In vitro studies, pharmacokinetic studies and clinical use of a high purity double virus inactivated FVIII/VWF concentrate (Immunate) in the treatment of von Willebrand disease.

Ver Elst KM, van Vliet HD, Kappers-Klunne MC, Leebeek FW. Ver Elst KM, et al. Among authors: leebeek fw. Thromb Haemost. 2004 Jul;92(1):67-74. doi: 10.1160/TH04-02-0107. Thromb Haemost. 2004. PMID: 15213847

6

The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.

van Goor ML, Gómez García E, Leebeek F, Brouwers GJ, Koudstaal P, Dippel D. van Goor ML, et al. Thromb Haemost. 2005 Jan;93(1):92-6. doi: 10.1160/TH04-09-0560. Thromb Haemost. 2005. PMID: 15630497

7

Temporary relief of symptomatic Von Willebrand disease by multiple myeloma.

Auwerda JJ, Sonneveld P, Leebeek FW. Auwerda JJ, et al. Among authors: leebeek fw. J Thromb Haemost. 2005 May;3(5):1088-9. doi: 10.1111/j.1538-7836.2005.01269.x. J Thromb Haemost. 2005. PMID: 15869614 Free article. No abstract available.

8

Hypofibrinolysis during induction treatment of multiple myeloma may increase the risk of venous thrombosis.

van Marion AM, Auwerda JJ, Minnema MC, van Oosterom R, Adelmeijer J, de Groot PG, Leebeek FW, Sonneveld P, Lokhorst HM, Lisman T. van Marion AM, et al. Among authors: leebeek fw. Thromb Haemost. 2005 Dec;94(6):1341-3. doi: 10.1160/th05-06-1341. Thromb Haemost. 2005. PMID: 16411420 Clinical Trial. No abstract available.

9

Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity.

Lisman T, Bongers TN, Adelmeijer J, Janssen HL, de Maat MP, de Groot PG, Leebeek FW. Lisman T, et al. Among authors: leebeek fw. Hepatology. 2006 Jul;44(1):53-61. doi: 10.1002/hep.21231. Hepatology. 2006. PMID: 16799972

10

High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability.

Bongers TN, de Maat MP, van Goor ML, Bhagwanbali V, van Vliet HH, Gómez García EB, Dippel DW, Leebeek FW. Bongers TN, et al. Among authors: leebeek fw. Stroke. 2006 Nov;37(11):2672-7. doi: 10.1161/01.STR.0000244767.39962.f7. Epub 2006 Sep 21. Stroke. 2006. PMID: 16990571

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

434 results

Search Page

Filters